Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 7 8 9 10 presentations: 1 to 25 of 243
Biosimilar biologic products: The US FDA perspective
Joseph Franklin
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biologic complexity: Implications for biosimilar development
Simon Hotchin
Amgen, Inc., Thousand Oaks, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biosimilar development: Clinical implications and applications
Sara A Hurvitz
UCLA, Santa Monica, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biosimilar regulatory policy: Understanding the landscape and relevance to medical practice
Sue Lim
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Re-inforcing vulnerable epigenetic states in rare embryonal pediatric brain tumors
Annie A Huang
The Hospital for Sick Children, Toronto, ON, Canada
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Uncovering context dependent drivers in embryonal brain tumors using transposon modelling
David A Largaespada
Univ. of Minnesota, Minneapolis, MN, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Cell context and consequence of oncogenic histone mutations in pediatric gliomas
Suzanne J Baker
St. Jude Children's Research Hospital, Memphis, TN, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Leveragingchromatin states to pinpoint therapeutic targets in pediatric ependymoma
Stephen C Mack
Baylor College of Medicine, Houston, TX, Canada
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Introduction: Epigenetic-driven cancers: challenges and opportunities
Nada Jabado
McGill Univ., Montréal, QC, Canada
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Histone H3 variants and human cancer
Peter W Lewis
University of Wisconsin-Madison, Madison, WI, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Subgroup-specific enhancer hijacking in medulloblastoma
Paul A Northcott
St. Jude Children's Research Hospital, Memphis, TN, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Deregulation of H3K36 methylation pathways in cancer
Chao Lu
Columbia University, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Epigenetic dysregulation and mutational partnerships in pediatric glioma
Jacek Majewski
McGill University and Genome Quebec Innovation Centre, Montreal, QC, Canada
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Translational control of cancer via the mRNA 5’-cap binding complex, eIF4F
Nahum Sonenberg
McGill Univ., Montreal, QC, Canada
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Targeted profiling of RNA translation for studying mTOR-dependent and-independent translational regulation
Jean J Zhao
Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Translating the cancer genome one codon at a time and its therapeuticimplications
Davide Ruggero
UCSF Helen Diller Family Comp. Cancer Ctr., San Francisco, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Translating translational control to the clinic in breast and ovariancancer
Robert J Schneider
New York Univ. School of Medicine, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Chair
Timothy Heffron
Genentech, Inc., South San Francisco, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 3:15 PM-5:15 PM
Challenges and principles of drug design in neuro-oncology
Zoran Rankovic
St. Jude Children's Research Hospital, Memphis, TN, United States
from AACR Annual Meeting 2018 on April 14, 2018 3:15 PM-5:15 PM
Strategies in the discovery of GDC-0084: A BBB penetrating PI3K/mTOR inhibitor
Timothy Heffron
Genentech, Inc., South San Francisco, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 3:15 PM-5:15 PM
Discovery of the clinical candidate AZD1390: A high quality, potent and selective inhibitor of ATM kinase with the ability to cross the blood brain barrier
Kurt G Pike
AstraZeneca, Cambridge, United Kingdom
from AACR Annual Meeting 2018 on April 14, 2018 3:15 PM-5:15 PM
Structural data in the discovery of lorlatinib and insights into mechanisms of ALK acquired resistance
Ted W. Johnson
Pfizer, Inc., San Diego, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 3:15 PM-5:15 PM
Chairperson
Benjamin G Neel
New York Univ. Langone Medical Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 3:15 PM-5:15 PM
Restoration of TET function as a therapeutic strategy in leukemia
Luisa Cimmino
NYU School of Medicine, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 3:15 PM-5:15 PM
Epigeneticregulation of stem cell function and leukemia suppression by vitamin C
Sean J Morrison
UT Southwestern University, Dallas, TX, United States
from AACR Annual Meeting 2018 on April 14, 2018 3:15 PM-5:15 PM
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 7 8 9 10 presentations: 1 to 25 of 243